Related Experiment Video
Updated: Jun 10, 2026

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level
Published on: January 19, 2024
The economic burden of anemia in heart failure
1Haemonetics, 400 Wood Road, Braintree, MA 02164, USA. rkspence@ix.netcom.com
Insights
Anemia in heart failure (HF) patients is no longer overlooked. Understanding its causes, outcomes, and treatments is crucial for managing the economic burden of HF.
Area of Science:
- Cardiology
- Hematology
- Health Economics
Background:
- Anemia is a common comorbidity in heart failure (HF) patients.
- Historically, anemia in HF was often accepted without targeted intervention.
- Improved understanding of anemia's impact and new treatments have shifted clinical perspectives.
Purpose of the Study:
- To review the prevalence, etiology, and outcomes of anemia in heart failure.
- To analyze the effectiveness, risks, benefits, and costs of anemia treatments in HF.
- To assess the overall economic burden of anemia on heart failure patients.
Main Methods:
- Literature review of studies on anemia in heart failure.
- Analysis of treatment strategies and their cost-effectiveness.
- Examination of the economic impact of anemia prevalence and management.
Main Results:
- Anemia significantly impacts heart failure patient outcomes and healthcare costs.
- Targeted treatments for anemia in HF are becoming more prevalent.
- Debate continues regarding the cost-effectiveness of specific anemia interventions in HF.
Conclusions:
- A comprehensive understanding of anemia in HF is essential for effective patient management.
- Evaluating treatment efficacy, risks, benefits, and costs is critical for addressing the economic burden.
- This review highlights the multifaceted impact of anemia on the economic landscape of heart failure care.
Abstract:
Anemia is a complex issue in patients with heart failure (HF). In past years, clinicians accepted anemia as a given or an "accessory" diagnosis in HF patients. This attitude has changed since understanding of the causes and morbidity of anemia in HF has improved and with the introduction of targeted treatments. Increasing health care costs have stimulated vigorous debate about the cost-effectiveness of such treatments. It behooves clinicians to understand the effectiveness of specific treatments, risks and benefits, and costs. This review addresses the impact of anemia's prevalence, etiology, associated outcomes, and treatments on the economic burden of HF patients.
Related Concept Videos
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Pathophysiology of Heart Failure
Heart Failure VII: Nursing Interventions
Heart Failure I: Introduction
Heart Failure II: Pathophysiology
Heart Failure III: Clinical Manifestations
